2024 Controversies in Hematologic Malignancies Symposium

Milwaukee, WI US
March 2, 2024

This one-day symposium will raise and address the most challenging questions in current clinical practice for hematologic malignancy. Topics will include navigating frontline therapies in DLBCL, Clonal Hematopoiesis, transfusion medicine, immunotherapies in myeloma, BiTE Lymphoma treatment, and much more. 

Target Audience

Physicians, Physician Assistants, Nurse Practitioners, Registered Nurses and Allied Health Professionals

Learning Objectives

Participants who engage in this educational intervention will be able to: 

  • Examine bispecific antibody treatments  for Non-Hodgkin Lymphoma.
  • Describe recommendations designed to improve immunotherapy treatment of multiple myeloma based on current advancements and trial results.
  • Identify the role of allogenic hematopoietic stem cell transplant for higher-risk MDS.
Additional information
AttachmentSize
PDF icon CAR-T Cells and Bispecific Antibody Therapy for Myeloma6.6 MB
PDF icon Devata-DLBCL-Frontline.pdf3.51 MB
PDF icon Bispecific Therapy in NHL_032024.pdf3.92 MB
PDF icon Harrington - Myeloid classification 2024 draft.pdf2.12 MB
PDF icon Taking a BiTE out of Bispecific Antibodies in Lymphoma - EAschenbrenner.pdf2 MB
PDF icon Treml Transfusion Medicine.pdf803.18 KB

Contact

Name: 
Dan Bullock
Phone Number: 
+1 (414) 805-4617
Email: 
danbullock@mcw.edu
Course summary
Available credit: 
  • 4.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 4.25 Hours of Participation
    Hours of Participation credit.
Course opens: 
12/09/2023
Course expires: 
05/11/2024
Event starts: 
03/02/2024 - 8:00am CST
Event ends: 
03/02/2024 - 2:00pm CST
Cost:
$0.00
Add to calendar: 

7:30 - 8:25 a.m. View Exhibits/Breakfast

8:25 – 8:30 a.m. Introduction

Leukemia Block:

8:30 – 8:50 a.m.              Myeloid Classification in 2024 – Alexandra Harrington

8:50 – 9:30 a.m.              Clonal Hematopoiesis – Uma Borate 

9:30 – 9:45 a.m.              Panel Q&A with Presenters

9:45 – 10:00 a.m.            Break

Myeloma Block:

10:00 – 10:20 a.m.          Management of Newly Diagnosed Myeloma – Othman Akhtar

10:20 – 11:00 a.m.          Update on CAR T-Cells and Bispecific Antibody Therapy of Myeloma – Larry Anderson

11:00 – 11:15 a.m.          Panel Q&A with Presenters

11:15 – 11:30 a.m.          Break

Breakout Sessions

11:30 a.m. – 12:00 p.m.                Navigating the Bermuda Triangle of Transfusion Medicine & the Oncology Patient – Angela Treml

                                                           Taking a "BiTE" Out of Bispecific Antibodies in Lymphoma: Applications for Treatment Implementation – Emilie Aschenbrenner

 

12:00 p.m. – 12:45 p.m.                Lunch

Lymphoma Block:

12:45 – 1:05 p.m.             Frontline DLBCL - Sumana Devata

1:05 – 1:45 p.m.               Bispecific Therapy in Lymphomas - Sonali Smith

1:45 – 2:00 p.m.               Panel Q&A with Presenters

 

Saint Kate Art Hotel
139 E Kilbourn Ave
Milwaukee, WI 53202
United States
+1 (414) 271-7250
Saint Kate Art Hotel
In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
 
Karen Sue Carlson, MD, PhD
Associate Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
 
Othman S. Akhtar, MD
Assistant Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
 
Angela Treml, MD
Associate Professor
Department of Pathology
Medical College of Wisconsin
 
Alexandra Harrington, MD, MT
Professor, Pathology
Medical College of Wisconsin
 
Sumana Devata, MD
Associate Professor
Division of Hematology and Oncology
Medical College of Wisconsin
 
 
The following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest mitigation process and addressed.
 
NameCompanyRole

Emilie Aschenbrenner, PharmD, BCOP

AbbVie, Genmab

Speaker

Sonali M. Smith, MDGenmab, Gilead, Ono Pharmaceuticals

Consultant

Uma Borate, MD, MSc

AbbVie, Incyte, Jazz Pharmaceuticals, Pfizer, RUNX1 Foundation

Genentech, Agios, Novartis, Blueprint, Astellas, Takeda, Kura, Servier

Researcher

Advisory Commitee

Larry Anderson, MD

Janssen, Celgene, Bristol Myers Squibb, Amgen, GSK, AbbVie, BeiGene, Cellectar, Sanofi

BMS, Celgene, AbbVie, and Janssen

Consultant

Researcher

 

 

ACCME Accreditation Statement: 
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 
 
AMA Credit Designation Statement: 
The Medical College of Wisconsin designates this for a maximum of 4.25 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 
 
Hours of Participation for Allied Health Care Professionals: 
The Medical College of Wisconsin designates this activity for up to 4.25 hours of participation for continuing education for allied health professionals.  

Available Credit

  • 4.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 4.25 Hours of Participation
    Hours of Participation credit.

Price

Cost:
$0.00
Please login or register to take this course.